Keywords: pharmacopeia, acquires, b-ms, sarm, program, clinical, development-stage

Pharmacopeia acquires B-MS' SARM program

Article | 22 October 2007

Clinical development-stage biopharmaceutical company Pharmacopeia says it has signed a licensing agreement with fellow USA-based firm Bristol-Myers Squibb, under which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in